🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Diamond Hill Capital’s MLAB Holdings & Trades

First Buy
Q4 2024
Duration Held
6 Quarters
Largest Add
Q3 2025
+84,582 Shares
Current Position
155,302 Shares
$13.73 M Value

Diamond Hill Capital's MLAB Position Overview

Diamond Hill Capital (via Diamond Hill Capital Management INC) currently holds 155,302 shares of Mesa Laboratories, Inc. (MLAB) worth $13.73 M, representing 0.09% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 6 quarters.

Based on 13F filings, Diamond Hill Capital has maintained this position in MLAB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 84,582 shares.

Analysis based on 13F filings available since 2013 Q2

Diamond Hill Capital's Mesa Laboratories (MLAB) Holding Value Over Time

Track share changes against reported price movement

Quarterly Mesa Laboratories (MLAB) Trades by Diamond Hill Capital

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2026 +13,329 Add 9.39% 155,302 $88.42
Q4 2025 +18,592 Add 15.07% 141,973 $78.50
Q3 2025 +84,582 Add 218.00% 123,381 $67.01
Q2 2025 +9,341 Add 31.71% 38,799 $94.22
Q1 2025 +2,824 Add 10.60% 29,458 $118.66
Q4 2024 +26,634 New Buy 26,634 $131.87

Diamond Hill Capital's Mesa Laboratories Investment FAQs

Diamond Hill Capital first purchased Mesa Laboratories, Inc. (MLAB) in Q4 2024, acquiring 26,634 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Diamond Hill Capital has held Mesa Laboratories, Inc. (MLAB) for 6 quarters since Q4 2024.

Diamond Hill Capital's largest addition to Mesa Laboratories, Inc. (MLAB) was in Q3 2025, adding 123,381 shares worth $8.27 M.

According to the latest 13F filing for Q1 2026, Diamond Hill Capital's firm, Diamond Hill Capital Management INC, owns 155,302 shares of Mesa Laboratories, Inc. (MLAB), valued at approximately $13.73 M.

As of the Q1 2026 filing, Mesa Laboratories, Inc. (MLAB) represents approximately 0.09% of Diamond Hill Capital's publicly disclosed stock portfolio, making it one of their key holdings.

Diamond Hill Capital's peak holding in Mesa Laboratories, Inc. (MLAB) was 155,302 shares, as reported at the end of Q1 2026.